Use Able AI chat for product recommendations
  • Featured Product
  • KD/KO Validated

CDR2L Monoclonal antibody

CDR2L Monoclonal Antibody for WB, IHC, IF/ICC, ELISA

Cat No. 66791-1-Ig
Clone No. 2E12D10
Publications (2)
Review Product
Download datasheet

Host / Isotype

Mouse / IgG1

Reactivity

Human, Mouse, Rat and More (1)

Applications

WB, IHC, IF/ICC, IP, ELISA

CDR2L, HUMPPA, Paraneoplastic 62 kDa antigen

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
PBS Only
Conjugate:  Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for CDR2L in ?

Tested Applications

Positive WB detected inU-251 cells, HEK-293 cells, K-562 cells, human brain tissue, rat brain tissue, mouse brain tissue
Positive IHC detected inhuman cerebellum tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHEK-293 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:6000
Immunohistochemistry (IHC)IHC : 1:200-1:800
Immunofluorescence (IF)/ICCIF/ICC : 1:400-1:1600
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

66791-1-Ig targets CDR2L in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with Human, Mouse, Rat samples.

Tested Reactivity Human, Mouse, Rat
Cited Reactivityhuman
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen

CatNo: Ag6139

Product name: Recombinant human CDR2L protein

Source: e coli.-derived, PET28a

Tag: 6*His

Domain: 110-459 aa of BC047534

Sequence: TETIERLQAQVEELQAQVEQLRGLEQLRVLREKRERRRTIHTFPCLKELCTSPRCKDAFRLHSSSLELGPRPLEQENERLQTLVGALRSQVSQERQRKERAEREYTAVLQEYSELERQLCEMEACRLRVQELEAELLELQQMKQAKTYLLGPDDHLAEALLAPLTQAPEADDPQPGRGDDLGAQDGVSSPAASPGHVVRKSCSDTALNAIVAKDPASRHAGNLTLHANSVRKRGMSILREVDEQYHALLEKYEELLSKCRQHGAGVRHAGVQTSRPISRDSSWRDLRGGEEGQGEVKAGEKSLSQHVEAVDKRLEQSQPEYKALFKEIFSRIQKTKADINATKVKTHSSK

Predict reactive species
Full Name cerebellar degeneration-related protein 2-like
Calculated Molecular Weight 53 kDa
Observed Molecular Weight 54 kDa
GenBank Accession NumberBC047534
Gene Symbol CDR2L
Gene ID (NCBI) 30850
RRIDAB_2882135
Conjugate Unconjugated
FormLiquid
Purification MethodProtein G purification
UNIPROT IDQ86X02
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Cerebellar degeneration-related protein 2-like(CDR2L), also named as HUMPPA or Paraneoplastic 62 kDa antigen, is a 465 amino acid protein, which belongs to the CDR2 family. CDR2L contains three potential coiled-coil regions. The functions of protein is so far not known. CDR2L is expressed in the brain and localizes in the cytoplasm.

Protocols

Product Specific Protocols
IF protocol for CDR2L antibody 66791-1-IgDownload protocol
IHC protocol for CDR2L antibody 66791-1-IgDownload protocol
WB protocol for CDR2L antibody 66791-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The CDR2L Monoclonal antibody (2E12D10), catalog number 66791-1-Ig, has 2 total citations. These appear in Annals of Clinical and Translational Neurology and Surgical Case Reports. The associated research fields include paraneoplastic cerebellar degeneration and anti-Yo antibody-associated paraneoplastic neurological syndrome in breast cancer. The cited application is immunoprecipitation (IP) in human samples.

SpeciesApplicationTitle
humanIP

Ann Clin Transl Neurol

Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration.

Authors - Ida Herdlevaer

Surg Case Rep

Breast Cancer with Subacute Progressive Neurological Symptoms due to Anti-Yo Antibody-Associated Paraneoplastic Neurological Syndrome: A Case Report.

Authors - Moe Tasaki
Loading...
||
New chat

Able™

正在加载,请稍候...